Coravas-C 75

CORAVAS-C 75 (Atorvastatin 10 mg + Clopidogrel 75 mg) Capsule is a combination of two medicines used to prevent heart attack and stroke. This medicine reduces the "bad" cholesterol (LDL) and triglycerides (fats) levels. Moreover, it also decreases the formation of blood clots.

It  is a clinically trusted dual-action cardiovascular therapy designed for patients at risk of atherosclerotic events. It combines a potent statin with a proven antiplatelet agent to support comprehensive protection against heart attack, stroke, and other thrombotic complications.This  formulation works by reducing cholesterol levels and preventing platelet aggregation, thereby minimizing plaque formation and clot development in blood vessels. CORAVAS-C 75 (Atorvastatin 10 mg + Clopidogrel 75 mg)  is widely prescribed as part of a complete cardiovascular care plan that includes lifestyle modification such as a healthy diet, regular exercise, smoking cessation, and weight. Lifestyle changes like low-fat diet, exercise and not smoking may help this medicine to work better. 

How Does CORAVAS-C 75 (Atorvastatin 10 mg + Clopidogrel 75 mg) Work?

Atorvastatin Component:

Inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis

Reduces LDL (“bad” cholesterol) and triglyceride levels

Increases HDL (“good” cholesterol)

Stabilizes atherosclerotic plaques

Clopidogrel Component:

Inhibits platelet aggregation by blocking ADP receptors

Prevents clot (thrombus) formation in blood vessels

Reduces risk of arterial blockage

This dual mechanism ensures both lipid control and clot prevention, offering superior cardiovascular protection.

Clinical Benefits of CORAVAS-C 75

Dual Cardiovascular Protection: Combines lipid-lowering and antiplatelet action

Reduces Risk of Heart Attack & Stroke: Effective in both primary and secondary prevention

Prevents Thrombus Formation: Minimizes risk of clot-related complications

Improves Lipid Profile: Lowers LDL and triglycerides while supporting HDL

Stabilizes Plaques: Reduces chances of rupture and acute cardiac events

Ideal for High-Risk Patients: Especially beneficial in diabetes, hypertension, and CAD patients

Dosage & Administration

The dosage of CORAVAS-C 75 should be determined by the physician based on the patient’s clinical condition, risk profile, and response to therapy.

Usually administered once daily

Can be taken with or without food

Regular monitoring of lipid profile and bleeding parameters is recommended

Disclaimer

Use only as prescribed by a healthcare professional. Not recommended in active bleeding conditions, severe liver disease, pregnancy, or lactation. Do not exceed the prescribed dose. Keep out of reach of children. Store in a cool, dry place away from light and moisture.